Found 1139 matching trials
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer PHASE1 This phase I trial studies the side effects and best dose of stereotactic b...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma PHASE2 The investigators conducted a phase II, prospective, two-arm clinical study...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy PHASE2 Radiotherapy can activate local and systemic immune responses through a var...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Pembrolizumab PHASE2 This multi-institutional, phase 2 clinical trial is studying two doses of p...
Show More Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Effect of Different Treatments on the Prognosis of Early Cervical Cancer: A Multicenter, Prospective, Real-world Study N/A To observe the effects of different treatments on the oncological outcome a...
Show More Location
Nanfang Hospital of Southern Medical University
Learn More & Join Trial
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. PHASE2 This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Show More Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Learn More & Join Trial
PET in Breast Cancer Receiving Neoadjuvant Chemotherapy PHASE2 Prognostic factors in locally advanced breast cancer treated with neoadjuva...
Show More Location
Multiple Locations
Learn More & Join Trial